APAP and Salicylate Poisoning - PowerPoint PPT Presentation

1 / 14
About This Presentation
Title:

APAP and Salicylate Poisoning

Description:

Title: APAP and Salicylate Poisoning Author: Corinne Hohl Last modified by: el mohnds Created Date: 9/8/2003 2:13:21 PM Document presentation format – PowerPoint PPT presentation

Number of Views:80
Avg rating:3.0/5.0
Slides: 15
Provided by: Cori89
Category:

less

Transcript and Presenter's Notes

Title: APAP and Salicylate Poisoning


1
Salicylates
2
-Salicylic Acid salts absorbed rapidly GI tract
serum concentrations 2/3 of dose in 1hr peak
2-4hrs -ASA hydrolyzed to free Salicylic acid
via RBC, Liver, Intestinal wall reversibly
binds albumin -Free Salicylate conjugates
excretion is Renal -If Poisoning underestimated
leads to metabolic acidosis, seizure,
hyperthermia, pulmonary edema, cerebral edema,
renal failure Death
3
ASA dosing
  • Adult acc. to the FDA
  • 650mg po /4h for
  • Initial dose can be 1000mg.
  • ? max 3900mg/day for adults
  • Child no more than 15mg/kg q4

4
Factors which may delay salicylate absorption in
an OD situation
  • Enteric coating
  • Salicylate-induced pylorospasm
  • Gastric outlet obstruction
  • Concomitant ingestion of sustance which decreases
    gastric motility

5
Factors which enhance the toxicity of topical
salicylates (i.e. oil of wintergreen)?
  • heat
  • occlusive dressings
  • young age (high BSA to weight ratio)
  • inflammation
  • psoriasis/break of the skin
  • long application
  • real danger is through oral ingestion of
    topical ingestion.

6
Acute vs. chronic
MORE DANGEROUS!
Features Acute Chronic Age Young
adult Older adult/infants Etiology OD Therapeut
ic misuse Co-ingest. Frequent Rare Past
history OD or psych pain/RF Presentation Early
Late Dehydration Moderate Severe Mental status
Normal(initially) Altered Serum conc 40 - 120
mg/dL 30 to 80 mg/dL Mortality Low w/
treatment High
7
methylsalicylate
Free tissue SA
90 of free SA binds albumin at conc lt 10mg/dL
2.5 excreted unchanged in urine (pH independent)
8
Metabolism in OD
  • Metabolizing enzymes get saturated switch from
    first ? zero order kinetics.
  • Decrease in albumin binding at toxic levels.
  • Urinary excretion is fixed.
  • SA weak acid
  • at physiologic pH most SA is ionized ? does not
    penetrate tissues well.
  • acidosis ? more unionized SA ? greater tissue
    penetration.

9
Mechanism of toxicity
Mechanism of toxicity -Salicylate stimulates
medullary respiratory center hyperpnea,
tachypnea ,respiratory alkalosis -Inhibition of
Krebs cycle ? ? amounts lactic pyruvic
acid. -Uncoupling oxidative phosphorylation ?
metabolism Temp, with ? CO2 production O2 use,
? glycolysis -?K Vomiting, ? Renal Na,K,HCO3
loss -Uncoupling OP also ? K by inhibiting
active transport
10
Met acidosis in ASA
  • Salicylate ion weak acid which contributes to
    the acidosis.
  • Dehydration from hyperpnea, vomiting, diaphoresis
    and hyper-thermia contributes to lactic acidosis.
  • Uncoupling of mitochondrial oxidative
    phosphorylation ? anaerobic metabolism ? lactate
    and pyruvate production.
  • Increased fatty acid metabolism (as a consequence
    of uncoupling of oxydative phosphorylation) ?
    lipolysis ? ketone formation.
  • In compensation for the initial respiratory
    alkalosis the kidneys excrete bicarbonate which
    later contributes to the metabolic acidosis.
  • Increased sodium and potassium accompany the
    initial renal bicarbonate diuresis ? hypokalemia
    ? hydrogen ion shift out of cell to maintain
    electrical neutrality.
  • Renal dysfunction ? accumulation of SA
    metabolites which are acids sulfuric and
    phosphoric acids.

11
Clinical manifestations
  • CNS tinnitus, decreased hearing, vertigo,
    hallucinations, agitation, hyperactivity,
    delirium, stupor, coma, lethargy, seizures,
    cerebral edema
  • Hem hypoprothrombinemia, platelet dysfunction
    and bleeding
  • GI n/v, hemorrhagic gastritis, decreased GI
    motility, pylorospasm
  • Met fever, hyperglycemia, hypoglycemia, ketosis,
    ketonuria
  • Pulm tachypnea
  • Volume diaphoresis and dehydration.

12
Treatment
  • Treatment Goals prevent gt absorption, correct
    fluid acid-base deficit excretion
  • Gastric lavage ,Activated charcoal ,Cathartics.
  • Intubations ,ventilation and shock treatment in
    severely intoxicated victem.
  • Urine alkalization with sodium bicarbonate to
    correct acidosis.
  • Potassium replacement in case of hypokalemia.
  • Vit K for treatment hypoprothrombinemia.
  • Correct dehydration with saline and fluids.
  • Treat pulmonary oedema with oxygen and
    intubations.
  • Glucose to correct hypoglycaemia and to prevent
    CNS depression.
  • Treat seizures with diazepam.
  • Cooling blankets or ice tocorrect hyperpyrexia.
  • DIALYSIS IF Coma/Seizure, Hepatic failure, Pulm
    edema,or Severe acid-base imbalance

13
Ion trapping
  • ? the more acidic the compartment the more SA
    will be NONionized because SA is a weak acid (the
    stronger acids will dissociate and give off their
    H first.)
  • the more basic a compartment the more IONIZED SA
    will be because there is a relative lack of H ?
    so because SA is an acid it will give off its H
    and be ionized, i.e. trapped in that milieu.

14
Indications for hemodialysis in SA poisoned
patients.
  • Renal failure ,CHF
  • Pulmonary edema or acute lung injury
  • Refractory acidosis or electrolyte imbalance
    despite maximal therapy
  • Persistent CNS symptoms
Write a Comment
User Comments (0)
About PowerShow.com